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Under-5 childrenAbstract Background: To monitor the prevalence of rotaviral diarrhoea in under-5 children
(U5C) as a retrospective study in a tertiary care hospital during 1 year.
Methods: Suspected stool samples were diagnosed for rotavirus by an enzyme immunoassay kit.
The same stool samples were diagnosed for the detection of any secondary bacterial infection
through routine microbiological diagnosis.
Results and conclusions: Of the total 265 stool samples, 123 were diagnosed positive with rotaviral
infection, of which, 59 (50.86%) samples were from children in the age group of 0–12 months; fur-
ther, 28 (41.79%), 17 (58.52%), 14 (35.71%) and 5 (46.41%) were from age groups, 13–24, 25–36,
37–48 and 49–60 months, respectively. Cases of secondary bacteremia were with Klebsiella sp.,
Enterobacter sp., Escherichia coli and Shigella sp. in the stool samples in age groups as given: 14
(0–12 month), 3 (13–24 month), 2 (37–48 month) and 1 (25–36 month). Of the total 123 rotaviral
positive infants, 62 patients had fever and 100 patients had vomiting; while, 57, 47 and 10 patients
Rotaviral diarrhoea in under-ﬁve hospitalized children of Eastern India 47had ‘mild’, ‘moderate’ and ‘severe’ dehydration, respectively. Further, 34 and 89 rotaviral positive
children were with malnutrition and normal nutrition, respectively; while, 19, 89 and 15 patients
were hospitalized for 62, 3–6, and P7 days, respectively. Data sets for ‘severity of dehydration’
and ‘days of hospitalization’ were statistically signiﬁcant, with Kruskal–Wallis H-test, indepen-
dently. Of 142 rotaviral negative patients, 27 with bacterial diarrhoea, 6 with parasitic infections,
20 with antibiotic intolerance and 31 with lactose intolerance were recorded.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Enteropathogenic viruses, bacteria and parasites are most
widespread in India, because of several reasons such as, the
tropical climate itself, unclean general environment and obliv-
ious attitude towards personal cleanliness, particularly.1 All
these factors are active in urban slum ghettos and thickly
populated dwellings consisting of both marginalized and
well-healed mass. Similarly, multidrug resistant (MDR) enter-
opathogenic infections are one of the major causes of clinical
consternation in other developing countries too.2 Speciﬁcally,
diarrhoea is the most dominating cause of mortality in
under-5 children (U5C) in most countries.1 Rotaviral diar-
rhoea in U5C is noteworthy. For example, as recorded in
Kerala, India, January–May was the most prevalent period
for rotaviral diarrhoea in 35.9% stool samples of hospitalized
U5C.3 The prevalence of the infection is mostly under-reported
because of the lack of laboratory conﬁrmation in most hospi-
tals in India. Further, according to a survey in China, rotaviral
infection was reported in 151 cases per 1000 U5C.4 In selected
African countries, a survey recorded that rotavirus was the
major cause of severe diarrhoea in under-5 children, as well
as infants of 3–12 months age.5 A study from Turkey recorded
that most rotaviral gastroenteritis occurred in children aged
between 24 and 36 months, and the winter season was the peak
time of high prevalence.6 In Cameroon too, rotavirus was
recorded as the major cause of child mortality.7
About 0.087 million hospitalizations and 0.7 million pri-
mary health care consultations for gastroenteritis were
recorded in the European Union. There were 3.6 million epi-
sodes of rotaviral infection annually, from which 23.6 million
U5C suffered, with 231 death cases.8 In the USA too, rotavirus
was noted to cause about 0.41 million medical consultations,
more than 200,000 emergency visits, and about 50,000–
70,000 hospital admissions per year.9 To sum up, 0.5 million
diarrhoeal deaths from rotavirus occur per year worldwide10;
and in developing countries rotaviral gastroenteritis was
recorded in 0.8 million cases of child mortality per year, the
poor nutritional status in health care being the secondary
cause of the infections.11
Rotavirus is characterized by a well-known genetic diver-
sity and the most common strains of rotavirus worldwide are
serotypes, G1, G2 G3, G4 and G9. These strains are respon-
sible for 95% paediatric diarrhoea worldwide. From the
Indian serotypes diagnosed with the kit, Rotaclone using ‘en-
zyme linked immune sorbent assay’ with samples from 1827
enrolled children in Kerala, it was ascertained that the causa-
tive viral serotypes were, G1P, G2P and G9P.3 In a study
from the slums of New Delhi, it was determined that, the
G and P serotypes of the virus had the severity of diarrhoeain under-5 children. Around 23.5% children suffered from
rotaviral diarrhoea; it was recorded that, rotavirus in stool
samples was present throughout the year; around 10% diar-
rhoea cases were due to mixed serotypes of the virus.12 In
a study from southern India, G1–G4 and G9 were the com-
mon rotavirus serotypes in under-5 children. With reverse
transcriptase polymerase chain reaction (PCR) work, the
double stranded RNA fragments from individual isolates of
the virus were compared with the VP6 antigen coding gene.13
A Brazilian study too recorded the prevalence of G2P strains
of the virus in U5C.14 A surveillance of the rotavirus strains
in 14 countries of Sub-Saharan Africa indicated that the most
common infecting serotypes were P(8) and P(6).15 With both
urban slums and nearer marginalised tribal pockets depend-
ing on this philanthropic hospital for health care, a consider-
able number of diarrhoea cases are registered, which was the
impetus of this surveillance. The major causative organism of
diarrhoea in the U5C age group of patients was found to be
rotavirus in this zone.Materials and methods
Collection and processing of samples
Stool samples of hospitalised U5C having acute watery
diarrhoea were diagnosed for rotaviral infections by using
the enzyme immunoassay kit, Ridascreen rotavirus (C0901,
R-biopharm AG, Germany). The same stool samples were
also diagnosed for the detection of any secondary bacterial
infection through routine microbiological diagnosis.
Sociodemographic factors, onset and duration of symp-
toms, grade of dehydration and malnutrition of the patients
were recorded. Categorization of dehydration as ‘no dehydra-
tion’, ‘mild dehydration’, ‘some dehydration’ and ‘severe dehy-
dration’ for patients was done according to World Health
Organization guidelines.16 Malnutrition status was determined
according to the classiﬁcation of Indian Academy of
Paediatrics (IAP), based on body-weight for age; when a
child-weight was more than 80% of that expected for its age;
it was taken as a baby of normal nutrition.17
Processing of negative samples
The rotaviral negative stool samples were further processed for
determining the cause of diarrhoea. Samples were diagnosed
for other microbiological organisms through culture and sensi-
tivity test.2 Parasitic infections in the samples were diagnosed
by routine microscopy method.18 Lactose intolerance was
detected by Benedict test.19
Table 1 Distribution of rotavirus in stool samples of hospi-
talized under-5 children, n= 265 (100%).
Age
group
(month)
Samples
obtained
Positive samples
[95% CI]
Rotaviral patients with
secondary bacteremia
0–12 116 59 (50.86%)
[0.419–0.598]
14
13–24 67 28 (41.79%)
[0.307–0.537]
3
25–36 39 14 (35.89%)
[0.227–0.516]
1
37–48 29 17 (58.52%)
[0.407–0.745]
2
49–60 14 05 (35.71%)
[0.162–0.614]
–
Total 265 123 (46.41%)
[0.405–0.524]
20
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Of the total 265 stool samples, 123 were diagnosed rotaviral
positive, of which 59 (50.86%) samples were from children in
the age group of 0–12 months; further, 28 (41.79%), 17
(58.52%), 14 (35.71%) and 5 (46.41%) were from age groups,
13–24, 25–36, 37–48 and 49–60 months, respectively (Table 1).
Lots of 123 positive rotaviral stool samples were parallelly diag-
nosed for the presence of secondary bacteremia; 20 samples
yielded pathogenic bacteria species, Klebsiella, Enterobacter
sp., Escherichia coli and Shigella sp. The maximum number of
cases with secondary bacteremia in the stool samples are given
in succinct: 14 cases for 0–12 month, 3 cases (13–24 month), 2
cases (37–48 month) and 1 case (25–36 month) age groups.
Stool samples from patients in the age group of 49–60 months
did not have any secondary bacteraemia (Table 1). The preva-
lence of rotaviral diarrhoea was from March to August, with
the peak at June (Fig. 1).
Clinical manifestations occurring independently in rotavirus
infected patients were recorded (Tables 2 and 3). Of the 59 pos-
itive rotaviral infected patients in the age group 0–12 months,0
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Figure 1 Occurrence of rotavirus in stool samples from under-5
children with diarrhoea, in 2013.32 patients from fever and 54 patients from vomiting suffered
independently. The 95%CI values and standard error of differ-
ence being 10.137 for children with fever and vomiting clearly
indicated that the prevalence of these parameters had no signif-
icant pattern. On the basis of degree of dehydration, these 59
patients were further recorded of having no dehydration, mild
dehydration, some dehydration and severe dehydration for the
number of patients, 2, 24, 28 and 5, respectively (Table 2).
Kruskal–Wallis H test for the dehydration data set was signif-
icant at p= 0.020, which indicated that the degree of this
symptom was crucial in rotaviral infection. Again, based on
the nutritional status, of the same 59 patients, 51 patients were
of under-nutrition/malnutrition and the rest 8 patients were of
normal nutrition status. The 95% CI values and standard error
of difference being 8.762 for children with nutrition status
clearly indicated that the prevalence of these parameters had
no signiﬁcant pattern. Further, basing on the days of hospital-
ization, of these 59 patients, 8 patients for 62 days, 43 for
3–6 days and 8 forP7 days were hospitalized for acute watery
diarrhoea (Table 3). Kruskal–WallisH test for days of hospital-
ization data set was signiﬁcant at p= 0.044, which indicated
that the degree of this parameter was crucial in rotaviral infec-
tion. Likewise, the clinical features of the 28 rotaviral infected
patients in the age group of 12–24 months, 14 between
25–36 months, 17 between 37–48 months and 5 between
49–60 months, were recorded (Tables 2 and 3).
Of the total 265 stool samples, 142 were negative for rota-
virus. There were 57 negative samples from the patients of age
group of 0–12 months. Of these 57 patients, 4 patients were
diagnosed for bacterial diarrhoea, 6 were diagnosed for antibi-
otic intolerance, 20 were diagnosed for lactose intolerance and
the rest 27 were suspected for other viral infections, which may
be responsible for diarrhoea. Similarly, in the age groups,
12–24, 25–36, 37–48 and 49–60 months, stool samples negative
to rotavirus were diagnosed with other causes of diarrhoea. In
summary, of the 142 rotaviral negative patients, 27 patients
with bacterial diarrhoea, 6 with parasitic infections, 20 with
antibiotic intolerance, 31 with lactose intolerance were
recorded; while the rest 58 patients were suspected for other
viral infections responsible for diarrhoea (Table 4).Discussion
It was discernible from this surveillance that infants below the
age of 12 months were infected often with rotavirus in dry and
summer seasons. In addition to the enzyme immunoassay kit,
Ridascreen, as here, other diagnostic methods include the use
of Rotaclone and latex agglutination.20 These tests provide
rapid sensitive/speciﬁc results, but other advanced techniques
deﬁnitely include electron microscopy, culture and PCR work
with RNA from pathogens.20
Transmission of the rotavirus occurs via faecal to oral route
by person to person contact, fomite, food, water and respira-
tory aerosol. The virus enters through mouth, but replicates
in the epithelium of small intestine and has got an incubation
period of less than 48 h.21 Rotaviral gastroenteritis results in
dehydration with shock, electrolyte imbalance and increases
body temperature up to 102F, with eventual hospitalization.
The course of the disease starts with an incubation period of
1–3 days. If unchecked, the infection leads to death within
3–7 days.22 Infants ordinarily are affected much with a wide
Table 2 Distribution of rotaviral infected under-5 children basing on clinical features.
Age group
(month)
Rotaviral positive patients Clinical features
Fever (%)*
[95% CI]
Vomiting (%)*
[95% CI]
Dehydration**
Nil (%)
[95% CI]
Mild (%)
[95% CI]
Some (%)
[95% CI]
Severe (%)
[95% CI]
0–12 59 32 (54.23)
[0.417–0.663]
54 (91.52)
[0.813–0.967]
2 (03.38)
[0.003–0.12]
24 (40.67)
[0.3–0.53]
28 (47.45)
[0.353–0.60]
5 (08.47)
[0.033–0.19]
13–24 28 15 (53.57)
[0.36–0.705]
25 (89.28)
[0.72–0.97]
3 (10.71)
[0.03–0.28]
15 (53.57)
[0.36–0.7]
7 (25.00)
[0.124–0.44]
3 (10.71)
[0.72–0.97]
25–36 14 7 (50.00) 14 (100) 0 (0) 8 (57.14) 4 (28.57) 2 (14.28)
37–48 17 6 (35.29) 12 (70.58) 1 (05.88) 9 (52.94) 7 (41.17) 0 (0)
49–60 5 2 (40.00) 5 (100) 1 (20.00) 1 (20.00) 3 (60) 0 (0)
Total 123 62 100 7 57 47 10
Numbers in () are percent; numbers in [] are 95% CI values; *standard error of difference is 10.137; **the Kruskal–Wallis H test for the
dehydration data set was signiﬁcant at p= 0.020, degree of freedom= 3.
Table 3 Distribution of rotaviral infected under-5 children basing on nutritional status and days of hospitalization.
Age group
(month)
Rotaviral positive patients Nutritional status* Days of hospitalization**
Malnutrition (%) Normal (%) 62 (%) 3–6 (%) P7 (%)
0–12 59 8 (13.55)
[0.07–0.25]
51 (86.44)
[0.75–0.93]
8 (13.55)
[0.067–0.25]
43 (72.88)
[0.60–0.82]
8 (13.55)
[0.067–0.25]
13–24 28 10 (35.71)
[0.20–0.54]
18 (64.28)
[0.46–0.80]
5 (17.85)
[0.074–0.36]
20 (71.42)
[0.52–0.85]
3 (10.71)
[0.72–0.97]
25–36 14 6 (42.85) 8 (57.14) 0 (0) 13 (92.85) 1 (07.14)
37–48 17 7 (41.17) 10 (58.82) 4 (23.52) 10 (58.82) 3 (17.64)
49–60 5 3 (60.0) 2 (40.0) 2 (40.0) 3 (60) 0 (0)
Total 123 34 89 19 89 15
Numbers in () are percent; numbers in [] are 95% CI values; *standard error of difference is 8.7624; **the Kruskal–Wallis H test for dataset for
days of hospitalization was signiﬁcant at p= 0.044, degree of freedom= 2.
Table 4 Distribution of rotaviral negative patients based on different clinical causes for diarrhoea.
Age
group
(month)
Rotaviral negative
Patients
Bacterial
diarrhoea
Parasitic
infections
Antibiotic
intolerance
Lactose
intolerance
Suspected other viral
infections
0–12 57 4 0 6 20 27
13–24 39 4 1 4 8 22
25–36 25 6 2 6 3 8
37–48 12 8 1 2 0 1
49–60 9 5 2 2 0 0
Total 142 27 6 20 31 58
Total negative samples, 142 (265–123 = 142).
Rotaviral diarrhoea in under-ﬁve hospitalized children of Eastern India 49range of symptoms, fever, vomiting, dehydration, pain in
abdomen, loss of weight, including frank necrotising entero-
colitis.23 In adults however, rotaviral gastroenteritis con-
tributes only 3–5% of clinical presentation. Admittedly,
diarrhoea, dehydration and vomiting are the most common
symptoms along with unexplained fever in children of age,
1–5 years. Fortunately, the clinical features of rotaviral infec-
tion are non-speciﬁc and similar to the diseases caused by
other gastrointestinal pathogens; nevertheless, the latter are
more severe in adults. Indeed, the ﬁrst viral infection in chil-
dren is severe and any subsequent infection causes less severity.
Apart from severe gastroenteritis in children, rarely rotavirusis reported to cause infection of cerebrospinal ﬂuid in patients
with encephalopathy.24 Rotavirus infections are reported to
alter phosphorylation of p70S6K, mitogen activated kinase,
and myosin light chain.25 Induced, inﬂammatory agents such
as, prostaglandin E2, nitric oxide or altered corticosterone
levels damage villi of enterocytes in small intestine.25
Although the virus is internalized by enterocytes of small
intestine by an unknown mechanism, the viral RNA enters
the cell and viral proteins are generated that disrupt calcium
homoeostasis, ultimately triggering a chain of events that lead
to cell lysis. Rotavirus infection causes malabsorption by ente-
rocytes of sodium and potassium ions, letting the loss of ﬂuid;
50 R. Sarangi et al.the secretory component of the viral infection is linked to the
activation of secretion of chorine ion outwards. Infection also
induces the reduction of activities of alkaline phosphatase, lac-
tase, sucrose and maltase.26 Thus, the thwart of intake of
sodium and potassium ions and simultaneous release of chlo-
rine ions with an imbalance of calcium ions in cells lead to
the ultimate breakdown of the child. Indeed, a peptide, the
NSP4 is secreted after an early infection which triggers the dor-
mant calcium activated anionic channel. Concomitantly, the
stimulation of enteric nervous systems and villus ischaemia
are involved after stability of the viral RNA in epithelial cells
to cause the ‘rotaviral diarrhoea’.26
Mixed infections are common, and it has been demonstrated
that mixed infection with entero-toxic E. coli and rotavirus
caused a higher mortality rate than either diseases, individually.
In a surveillance, co-infection of rotavirus and E. coli (11.1–
45.5%), Salmonella sp. (0.5–4.8%), Giardia sp. (1.7–8.6%)
and Shigella ﬂexneri (3.2–8.0%) had been recorded from Iran;
also children with a mixed infection had the highest incidence
of severe vomiting, dehydration and fever.27 Mixed infections
might result from unhealthy environments to a larger extent
in urban slums; inocula of more diverse serotypes of rotavirus
along with enteropathogens prevalent in water or contaminated
food are the determinative causatives, as discussed.28
Development of vaccines for the virus had an effect on the
disease rate locally. Rotavirus vaccine is used with limitations
in children with well healed mass as this vaccine is not as pop-
ular as the polio vaccine. With this scenario of use of vaccina-
tion, the herd mechanism may be contributing to the rate of
prevalence.29 In India, two vaccines, Rotarix, a monovalent
P1A(8)G1 vaccine (GlaxoSmithkline) and Rotateq (Merck),
a pentavalent bovine human reassortant vaccine are used.29
In conclusion, it was seen in this region that infant/U5C
mortality could be due to rotavirus, in addition to the infection
from MDR enteropathogenic bacteria, since MDR pathogenic
bacteria are leitmotifs of each infectious episode in the commu-
nity or hospital setting. Nevertheless, rotaviral infection origi-
nates mostly from unhygienic communities. Recorded data for
severity of dehydration and days of hospitalization were
supported by signiﬁcance with Kruskal–Wallis H test. This
geographic zone too has a widespread distribution of
rotavirus, especially in dry season.
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